Remove Containment Remove Life Science Remove Regulation
article thumbnail

How AI/ML-based PHI & PII redaction solutions can help life sciences organizations

Cloudbyz

In today’s digital age, life sciences organizations are collecting, storing, and processing vast amounts of sensitive data, including personally identifiable information (PII) and protected health information (PHI). As such, it’s becoming increasingly challenging for organizations to manage and secure this data.

article thumbnail

Tiziana Life Sciences plc Posting of Scheme Document and Notice of Meetings

BioTech 365

Tiziana Life Sciences plc Posting of Scheme Document and Notice of Meetings Tiziana Life Sciences plc Posting of Scheme Document and Notice of Meetings THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU WHICH IS … Continue reading →

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Discovery of MicroRNA Genetic Regulation Leads American Scientists to Win 2024 Nobel Prize

XTalks

The 2024 Nobel Prize in Physiology or Medicine has been awarded to American scientists Victor Ambros and Gary Ruvkun for their groundbreaking discovery of microRNA (or miRNA) and its role in post-transcriptional gene regulation. A gene contains instructions within our DNA.

article thumbnail

PMPRB Update: delayed implementation of Patented Medicines Regulations amendments and new Guidelines

Pharma in Brief

Changes to the Patented Medicine Prices Review Board ( PMPRB ) regime, contained in pending amendments to the Patented Medicines Regulations , have been delayed until January 1, 2022. The amendments contain a number of changes affecting the PMPRB’s review of patented medicine prices.

article thumbnail

Abcam Announces Pricing of Offering on NASDAQ

BioTech 365

This Announcement Contains Inside Information for the Purposes of Article 7 of Regulation (EU) No 596/2014 LONDON, Oct. 22, 2020 (GLOBE NEWSWIRE) — Abcam plc (AIM: ABC) (“Abcam”), a global leader in the supply of life science research tools, announces … Continue reading →

article thumbnail

Tiziana Life Sciences announces collaboration with Parexel Biotech to conduct phase 1b/2 clinical trial in patients with Crohn’s Disease

The Pharma Data

Weiner, chairman of the scientific advisory board of Tiziana Life Sciences, commented: “We understand that this will be the first-ever study with ‘take-home’ capsules of any mAb for immunotherapies for human diseases. This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

article thumbnail

Health Canada releases updated Certificate of Supplementary Protection guidance

Pharma in Brief

The CSP Guidance was revised to reflect amendments to the definition of “authorization for sale” in the Certificate of Supplementary Protection Regulations ( CSP Regulations ) and to reflect changes to Health Canada’s administrative practices. Certificate of Supplementary Protection Regulations , SOR/2017-165